News

Filter

Current filters:

Merck SeronoManagement

Merck Serono creates second company under EPP

03-09-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has established Quartz Bio, the second spin-off…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalQuartz Bio

Merck Serono sets up Prexton Therapeutics as first spin-off from its Entrepreneur Partnership Program

31-07-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has created Prexton Therapeutics, the first…

BiotechnologyLicensingManagementMerck KGaAMerck SeronoNeurologicalPharmaceuticalPrexton TherapeuticsResearch

Merck KGaA to rationalize operations in Switzerland

24-04-2012

German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Merck Serono strengthens executive team; ProStrakan names new CEO; Sanofi Pasteur MSD gets new president

08-07-2011

German drug major Merck KGaA (MRK: DE) says it is strengthening its executive management team with two…

Kyowa Hakko KirinManagementMerck & CoMerck KGaAMerck SeronoPharmaceuticalProStrakanResearchSanofiSanofi Pasteur MSD

Back to top